Clarus Therapeutics Holdings Inc. Made Headway

Fri, Mar 25, 2022 at 05:30 PM
Clarus Therapeutics Holdings Inc. Made Headway

Clarus Therapeutics Holdings Inc. (CRXT:NASDAQ) soared at $1.65, representing a gain of 26%. On Thu, Mar 24, 2022, CRXT:NASDAQ touched a New 2-Week High of $1.31. The stock got featured on our News Catalysts scanner on Wed, Mar 16, 2022 at 10:01 AM in the 'BIOTECH' category. From Fri, Mar 11, 2022, the stock recorded 77.78% Up Days and 90.00% Green Days

The stock spiked on Mon, Mar 21, 2022 at $1.84 with a volume of 29M+.

About Clarus Therapeutics Holdings Inc. (CRXT:NASDAQ)

Clarus Therapeutics Holdings Inc is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.